Bio-Rad Laboratories (BIO) Other Non-Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Other Non-Current Liabilities for 18 consecutive years, with $198.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 5.3% year-over-year to $198.5 million in Q2 2026; TTM through Jun 2026 was $198.5 million, a 5.3% decrease from a year earlier, with the FY2025 full-year figure at $199.1 million, up 12.36% from the prior year.
• Other Non-Current Liabilities was $198.5 million for Q2 2026 at Bio-Rad Laboratories, roughly flat from $198.4 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $209.6 million in Q2 2025 and troughed at $173.1 million in Q1 2025.
• A 5-year average of $193.8 million and a median of $196.8 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities slipped 21.31% in 2022 and grew 14.62% in 2026, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $195.9 million in 2022, then decreased by 0.47% to $195.0 million in 2023, then fell by 9.13% to $177.2 million in 2024, then advanced by 12.36% to $199.1 million in 2025, then fell by 0.3% to $198.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $198.5 million (Q2 2026), $198.4 million (Q1 2026), and $199.1 million (Q4 2025), per Business Quant data.